Helicobacter pylori vaccine development: Optimisation of strategies and importance of challenging strain and animal model
- 3 January 2008
- journal article
- review article
- Published by Elsevier BV in International Journal of Medical Microbiology
- Vol. 298 (1-2), 151-159
- https://doi.org/10.1016/j.ijmm.2007.07.006
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Resistance of Primary Murine CD4 + T Cells to Helicobacter pylori Vacuolating CytotoxinInfection and Immunity, 2007
- Human Polymorphonuclear Leukocytes are Sensitive In Vitro to Helicobacter pylori VacA ToxinHelicobacter, 2006
- The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent MechanismsThe Journal of Experimental Medicine, 2003
- Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte ActivationScience, 2003
- The Design of Vaccines AgainstHelicobacter Pyloriand Their DevelopmentAnnual Review of Immunology, 2001
- Identification of iron-regulated genes ofHelicobacter pyloriby a modified Fur titration assay (FURTA-Hp)FEMS Microbiology Letters, 2000
- Virulent Strains of Helicobacter pylori Demonstrate Delayed Phagocytosis and Stimulate Homotypic Phagosome Fusion in MacrophagesThe Journal of Experimental Medicine, 2000
- Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted ResponsesThe Journal of Experimental Medicine, 1998
- Ecology of Helicobacter pylori in the human stomach.JCI Insight, 1997
- Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.Proceedings of the National Academy of Sciences, 1993